Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods

Ellen F Eaton,1 Chastity McDavid,1 Mary Katy Banasiewicz,1 Michael J Mugavero,1 Sara J Knight2 1Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 2Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmi...

Full description

Bibliographic Details
Main Authors: Eaton EF, McDavid C, Banasiewicz MK, Mugavero MJ, Knight SJ
Format: Article
Language:English
Published: Dove Medical Press 2017-09-01
Series:Patient Preference and Adherence
Subjects:
HIV
Online Access:https://www.dovepress.com/patient-preferences-for-antiretroviral-therapy-effectiveness-quality-o-peer-reviewed-article-PPA
id doaj-f141d7dbf12a49c99d3b5114a23e38e6
record_format Article
spelling doaj-f141d7dbf12a49c99d3b5114a23e38e62020-11-24T20:54:56ZengDove Medical PressPatient Preference and Adherence1177-889X2017-09-01Volume 111585159034763Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methodsEaton EFMcDavid CBanasiewicz MKMugavero MJKnight SJEllen F Eaton,1 Chastity McDavid,1 Mary Katy Banasiewicz,1 Michael J Mugavero,1 Sara J Knight2 1Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 2Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA Objective: The objective of this study was to understand patient preferences for contemporary antiretroviral therapy (ART) by focusing on three areas that have been understudied: minority patients (racial/ethnic and sexual minorities), experience with novel single-tablet regimens made available in the last 10 years, and patient concerns related to ART. The rationale was that identifying ART characteristics that are most desirable could inform provider prescribing practices, increase the use of patient-centered ART, maximize durability and ART adherence, and ultimately improve HIV outcomes, such as viral suppression and AIDS-related comorbidities.Methods: We recruited English- and Spanish-speaking persons living with HIV (PLWH) who were ≥19 years of age or older and had initiated ART after January 1, 2006, until saturation was reached (n=28). We excluded patients who had started on ART more than 10 years earlier, in order to ensure responses were relevant to more contemporary ART regimens. We recruited racial/ethnic and sexual minorities, including men who have sex with men and transgender participants, to reflect the current HIV epidemic. Nominal group technique was used to identify and prioritize preferences and concerns. Multi-voting analysis was used to quantify responses from most important (5 points) to least important (1 point).Results: For 28 diverse participants, clinical outcomes (162 points) and quality of life (120 points) were preferred. Hispanic participants were more concerned about accessibility than non-Hispanic (3.8 vs 1.9 average points/participant).Discussion: HIV-infected persons prioritize access, clinical outcomes, and quality of life when considering contemporary ART treatment. Providers, insurers and policy makers should incorporate these preferences when making decisions about ART. Keywords: HIV, preferences, immigrant, Hispanic, access to care https://www.dovepress.com/patient-preferences-for-antiretroviral-therapy-effectiveness-quality-o-peer-reviewed-article-PPAHIVantiretroviral therapypreferencesquality of life
collection DOAJ
language English
format Article
sources DOAJ
author Eaton EF
McDavid C
Banasiewicz MK
Mugavero MJ
Knight SJ
spellingShingle Eaton EF
McDavid C
Banasiewicz MK
Mugavero MJ
Knight SJ
Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods
Patient Preference and Adherence
HIV
antiretroviral therapy
preferences
quality of life
author_facet Eaton EF
McDavid C
Banasiewicz MK
Mugavero MJ
Knight SJ
author_sort Eaton EF
title Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods
title_short Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods
title_full Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods
title_fullStr Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods
title_full_unstemmed Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods
title_sort patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods
publisher Dove Medical Press
series Patient Preference and Adherence
issn 1177-889X
publishDate 2017-09-01
description Ellen F Eaton,1 Chastity McDavid,1 Mary Katy Banasiewicz,1 Michael J Mugavero,1 Sara J Knight2 1Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 2Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA Objective: The objective of this study was to understand patient preferences for contemporary antiretroviral therapy (ART) by focusing on three areas that have been understudied: minority patients (racial/ethnic and sexual minorities), experience with novel single-tablet regimens made available in the last 10 years, and patient concerns related to ART. The rationale was that identifying ART characteristics that are most desirable could inform provider prescribing practices, increase the use of patient-centered ART, maximize durability and ART adherence, and ultimately improve HIV outcomes, such as viral suppression and AIDS-related comorbidities.Methods: We recruited English- and Spanish-speaking persons living with HIV (PLWH) who were ≥19 years of age or older and had initiated ART after January 1, 2006, until saturation was reached (n=28). We excluded patients who had started on ART more than 10 years earlier, in order to ensure responses were relevant to more contemporary ART regimens. We recruited racial/ethnic and sexual minorities, including men who have sex with men and transgender participants, to reflect the current HIV epidemic. Nominal group technique was used to identify and prioritize preferences and concerns. Multi-voting analysis was used to quantify responses from most important (5 points) to least important (1 point).Results: For 28 diverse participants, clinical outcomes (162 points) and quality of life (120 points) were preferred. Hispanic participants were more concerned about accessibility than non-Hispanic (3.8 vs 1.9 average points/participant).Discussion: HIV-infected persons prioritize access, clinical outcomes, and quality of life when considering contemporary ART treatment. Providers, insurers and policy makers should incorporate these preferences when making decisions about ART. Keywords: HIV, preferences, immigrant, Hispanic, access to care 
topic HIV
antiretroviral therapy
preferences
quality of life
url https://www.dovepress.com/patient-preferences-for-antiretroviral-therapy-effectiveness-quality-o-peer-reviewed-article-PPA
work_keys_str_mv AT eatonef patientpreferencesforantiretroviraltherapyeffectivenessqualityoflifeaccessandnoveldeliverymethods
AT mcdavidc patientpreferencesforantiretroviraltherapyeffectivenessqualityoflifeaccessandnoveldeliverymethods
AT banasiewiczmk patientpreferencesforantiretroviraltherapyeffectivenessqualityoflifeaccessandnoveldeliverymethods
AT mugaveromj patientpreferencesforantiretroviraltherapyeffectivenessqualityoflifeaccessandnoveldeliverymethods
AT knightsj patientpreferencesforantiretroviraltherapyeffectivenessqualityoflifeaccessandnoveldeliverymethods
_version_ 1716793258469752832